London stocks closed with little direction on Friday as investors weighed fresh economic data, including signs of slowing ...
GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave its current price looking cheap to me?
Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...
GSK’s MenABCWY vaccine is an injectable suspension intended for intramuscular use. It comes with a vial of lyophilised ...
GSK, the tenth biggest pharmaceutical company in the world, is investing £50 million to establish the GSK–Oxford Cancer Immuno-Prevention Programme, aimed at advancing the development of a ...
White House Press Secretary Karoline Leavitt faced off with CNN's Kaitlan Collins Wednesday, over the White House's blocking ...
The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...
Alison Winder has been an assistant editor at the Royal Society of Chemistry since 2022 after several different science-based ...
Astex Pharmaceuticals has been celebrating a very successful first 25 years following a visit from Science minister Patrick ...
We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...
Hosted on MSN17d
Malaria could be wiped out in just 10 years as British jabs may be the key to saving hundreds of thousands of livesThe first successful vaccine, GSK's RTS,S jab, was given the green light for widespread use by the World Health Organisation (WHO) in July 2022, followed by Oxford University's R21 vaccine in December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results